Association between aquaporin 1 and malignant tumors

Abstract

Li Ping, Liu Xin, Liu Honglu, Wang Xicai. Association between aquaporin 1 and malignant tumors[J]. Journal of International Oncology, 2017, 44(7): 516-518.

［1］ Agre P, Preston GM, Smith BL, et al. Aquaporin CHIP: the archetypal molecular water channel［J］. Am J Physiol, 1993, 265(4 Pt 2): 463-476. ［2］ Ozu M, Dorr RA, Gutierrez F, et al. Human AQP1 is a constitutively open channel that closes by a membranetensionmediated mechanism［J］. Biophys J, 2013, 104(1): 85-95. DOI: 10.1016/j.bpj.2012.11.3818. ［3］ Agre P. Nobel Lecture. Aquaporin water channels［J］. Biosci Rep, 2004, 24(3): 127163. DOI: 10.1007/s1054000525772. ［4］ Mobasheri A, BarrettJolley R. Aquaporin water channels in the mammary gland: from physiology to pathophysiology and neoplasia［J］. J Mammary Gland Biol Neoplasia, 2014, 19(1): 91-102. DOI: 10.1007/s1091101393126. ［5］ Moosavi B, Shabana WM, ElKhodary M, et al. Intracellular lipid in clear cell renal cell carcinoma tumor thrombus and metastases detected by chemical shift (in and opposed phase) MRI: radiologicpathologic correlation［J］. Acta Radiol, 2016, 57(2): 241-248. DOI: 10.1177/0284185115572207. ［6］ Sreedharan S, Petros JA, Master VA, et al. Aquaporin1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions［J］. Dis Markers, 2014, 2014: 135649. DOI: 10.1155/2014/135649. ［7］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 9-29. DOI: 10.3322/caac.21208. ［8］ Khor LY, Tan PH. Diagnostic biomarkers in eosinophilic renal neoplasms［J］. Urol Clin North Am, 2016, 43(1): 8794. DOI: 10.1016/j.ucl.2015.08.008. ［9］ Mijugkovi′c M, Stanojevi′c I, Milovi′c N, et al. Urinary KIM1 and AQP1 in patients with clear renal cell carcinoma: potential noninvasive biomarkers［J］. Vojnosanit Pregl, 2016, 73(3): 266-272. ［10］ Morrissey JJ, London AN, Luo J, et al. Urinary biomarkers for the early diagnosis of kidney cancer［J］. Mayo Clin Proc, 2010, 85(5): 413-421. DOI: 10.4065/mcp.2009.0709. ［11］ Morrissey JJ, Kharasch ED. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma［J］. J Urol, 2013, 189(5): 1913-1920. DOI: 10.1016/j.juro.2012.11.034. ［12］ Morrissey JJ, Mobley J, Song J, et al. Urinary concentrations of aquaporin1 and perilipin2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade［J］. U rology, 2014, 83(1): 256， e914. DOI: 10.1016/j.urology.2013.09.026. ［13］ Morrissey JJ, Mellnick VM, Luo J, et al. Evaluation of urine aquaporin1 and perilipin2 concentrations as biomarkers to screen for renal cell carcinoma: a prospective cohort study［J］. JAMA Oncol, 2015, 1(2): 204-212. DOI: 10.1001/jamaoncol.2015.0213. ［14］ Morrissey JJ, Mobley J, Figenshau RS, et al. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer［J］. Mayo Clin Proc, 2015, 90(1): 35-42. DOI: 10.1016/j.mayocp.2014.10.005. ［15］ Otterbach F, Callies R, Adamzik M, et al. Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basallike breast carcinomas［J］. Breast Cancer Res Treat, 2010, 120(1): 67-76. DOI: 10.1007/s10549-009-0370-9. ［16］ EstevaFont C, Jin BJ, Verkman AS. Aquaporin1 gene deletion reduces breast tumor growth and lung metastasis in tumorproducing MMTVPyVT mice［J］. FASEB J, 2014, 28(3): 1446-1453. DOI: 10.1096/fj.13245621. ［17］ Zou LB, Shi S, Zhang RJ, et al. Aquaporin1 plays a crucial role in estrogeninduced tubulogenesis of vascular endothelial cells［J］. J Clin Endocrinol Metab, 2013, 98(4): E672-E682. DOI: 10.1210/jc.20124081. ［18］ Yun S, Sun PL, Jin Y, et al. Aquaporin 1 is an independent marker of poor prognosis in lung adenocarcinoma［J］. J Pathol Transl Med, 2016, 50(4): 251-257. DOI: 10.4132/jptm.2016.03.30. ［19］ Wei X, Dong J. Aquaporin 1 promotes the proliferation and migration of lung cancer cell in vitro［J］. Oncol Rep, 2015, 34(3): 1440-1448. DOI: 10.3892/or.2015.4107. ［20］ Kourghi M, Pei JV, De Ieso ML, et al. Bumetanide derivatives AqB007 and AqB011 selectively block the aquaporin1 ion channel conductance and slow cancer cell migration［J］. Mol Pharmacol, 2016, 89(1): 133-140. DOI: 10.1124/mol.115.101618. ［21］ Dorward HS, Du A, Bruhn MA, et al. Pharmacological blockade of aquaporin1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro［J］. J Exp Clin Cancer Res, 2016, 35: 36. DOI: 10.1186/s13046-016-0310-6. ［22］ Nicchia GP, Stigliano C, Sparaneo A, et al. Inhibition of aquaporin1 dependent angiogenesis impairs tumour growth in a mouse model of melanoma［J］. J Mol Med (Berl), 2013, 91(5): 613-623. DOI: 10.1007/s00109-012-0977-x.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Association between aquaporin 1 and malignant tumors

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments